XEOMIN 100 units, powder for solution for injection bottle
Active ingredients: TOXINE BOTULINIQUE TYPE A
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder for solution for injectionbottleintraglandulaire;intramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- XEOMIN 100 unités, poudre pour solution injectable
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intraglandulaire;intramusculaire
- Presentation description
- 1 flacon(s) en verre de 100 unité(s)
- Marketing authorisation holder
- MERZ THERAPEUTICS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 May 2008
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67540690CIP75718860CIP133400957188603Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TOXINE BOTULINIQUE TYPE Apoudre | 100 unités DL50 · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.